MARINA TSOY-PODOSENIN: Open Payments
NPI 1881001352 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,146 in 39 payments from 8 companies in 2025. Trend: 2023 $685 · 2024 $531 · 2025 $1,146
Food & beverage: $1,034Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $403 |
| E.R. Squibb & Sons, L.L.C. | 6 | $248 |
| Alkermes, Inc. | 7 | $166 |
| Otsuka America Pharmaceutical, Inc. | 6 | $141 |
| Luye Pharma (USA) Ltd. | 3 | $74 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: UZEDY, COBENFY, ABILIFY MAINTENA, ARISTADA, ERZOFRI EXTENDED-RELEASE, INVEGA SUSTENNA, LYBALVI, VIVITROL.
Industry payments across NY — which companies pay providers there.
